Geneos Wealth Management’s iShares MSCI Intl Quality Factor ETF IQLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Buy
19,770
+666
+3% +$32.5K 0.02% 549
2026
Q1
$883K Buy
19,104
+250
+1% +$11.8K 0.02% 540
2025
Q4
$857K Buy
18,854
+2,344
+14% +$105K 0.02% 538
2025
Q3
$730K Buy
16,510
+2,903
+21% +$125K 0.02% 559
2025
Q2
$588K Sell
13,607
-10,585
-44% -$439K 0.01% 663
2025
Q1
$960K Buy
24,192
+15,618
+182% +$616K 0.01% 675
2024
Q4
$318K Sell
8,574
-301
-3% -$11.8K 0.01% 693
2024
Q3
$368K Buy
8,875
+988
+13% +$39.4K 0.01% 624
2024
Q2
$308K Sell
7,887
-373
-5% -$14.6K 0.01% 599
2024
Q1
$328K Buy
8,260
+28
+0.3% +$1.07K 0.02% 581
2023
Q4
$309K Buy
8,232
+300
+4% +$10.5K 0.02% 573
2023
Q3
$267K Buy
7,932
+686
+9% +$24.1K 0.01% 606
2023
Q2
$258K Buy
7,246
+413
+6% +$14.7K 0.01% 619
2023
Q1
$241K Sell
6,833
-55
-0.8% -$1.89K 0.01% 610
2022
Q4
$223K Hold
6,888
0.01% 600
2022
Q3
$191K Sell
6,888
-17,383
-72% -$538K 0.01% 611
2022
Q2
$750K Sell
24,271
-7,915
-25% -$266K 0.04% 399
2022
Q1
$1.19M Buy
32,186
+1,730
+6% +$64K 0.05% 311
2021
Q4
$1.2M Buy
30,456
+5,452
+22% +$214K 0.05% 351
2021
Q3
$952K Buy
25,004
+17,476
+232% +$691K 0.04% 398
2021
Q2
$292K Buy
7,528
+1,896
+34% +$73.2K 0.01% 699
2021
Q1
$214K Sell
5,632
-26
-0.5% -$942 0.01% 938
2020
Q4
$207K Buy
5,658
+4,237
+298% +$142K 0.01% 813
2020
Q3
$44K Sell
1,421
-2,364
-62% -$73.7K ﹤0.01% 1310
2020
Q2
$110K Sell
3,785
-86,233
-96% -$2.41M 0.01% 875
2020
Q1
$2.29M Sell
90,018
-5,758
-6% -$172K 0.15% 150
2019
Q4
$3.1M Buy
95,776
+95,535
+39,641% +$2.96M 0.17% 152
2019
Q3
$7K Hold
241
﹤0.01% 2003
2019
Q2
$7K Hold
241
﹤0.01% 2015
2019
Q1
$7K Buy
+241
New +$6.74K ﹤0.01% 1949

Other funds holding IQLT

Geneos Wealth Management's IQLT Position: Q2 2026 in Review

Geneos Wealth Management increased its iShares MSCI Intl Quality Factor ETF (IQLT) stake by 3.5% in Q2 2026, buying an estimated $32.5K and bringing the position to 19,770 shares worth $980K. The position accounts for 0.02% of the portfolio, ranked #549.

Geneos Wealth Management first reported a position in IQLT in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.1M in Q4 2019. 639 funds tracked by Wall St. Rank hold IQLT as of Q2 2026.

  • Geneos Wealth Management held 19,770 shares of iShares MSCI Intl Quality Factor ETF worth $980K as of Q2 2026.
  • Geneos Wealth Management bought 666 iShares MSCI Intl Quality Factor ETF shares in Q2 2026, an estimated $32.5K.
  • iShares MSCI Intl Quality Factor ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #549 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI Intl Quality Factor ETF in Q1 2019 and has held it in 30 quarters since.
  • Geneos Wealth Management's iShares MSCI Intl Quality Factor ETF position peaked at $3.1M in Q4 2019.
  • 639 funds tracked by Wall St. Rank held iShares MSCI Intl Quality Factor ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.